BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 39,712,000 Value ($000) $39 Avg Close — Range —
Q1 2024
Shares 39,100,000 Value ($000) $38 Avg Close — Range —
Q4 2023
Shares 2,515,000 Value ($000) $2 Avg Close — Range —
Q3 2023
Shares 2,515,000 Value ($000) $2 Avg Close — Range —
Q2 2023
Shares 2,515,000 Value ($000) $2 Avg Close — Range —
Q1 2023
Shares 3,252,000 Value ($000) $3 Avg Close — Range —
Q4 2022
Shares 94,000 Value ($000) $0 Avg Close — Range —
Q1 2021
Shares 35,799,000 Value ($000) $36,314 Avg Close — Range —
Q4 2020
Shares 30,799,000 Value ($000) $33,127 Avg Close — Range —
Q3 2020
Shares 46,799,000 Value ($000) $49,225 Avg Close — Range —
Q2 2020
Shares 30,799,000 Value ($000) $37,715 Avg Close — Range —
Q1 2020
Shares 30,485,000 Value ($000) $32,022 Avg Close — Range —
Q4 2019
Shares 34,825,000 Value ($000) $36,879 Avg Close — Range —
Q3 2019
Shares 34,825,000 Value ($000) $34,319 Avg Close — Range —
Q2 2019
Shares 34,825,000 Value ($000) $36,239 Avg Close — Range —
Q1 2019
Shares 33,200,000 Value ($000) $34,050 Avg Close — Range —
Q4 2018
Shares 33,200,000 Value ($000) $33,097 Avg Close — Range —
Q3 2018
Shares 17,700,000 Value ($000) $18,908 Avg Close — Range —
Q4 2017
Shares 5,000,000 Value ($000) $4,993 Avg Close — Range —
Q3 2017
Shares 13,500,000 Value ($000) $13,710 Avg Close — Range —